Starling Oncology, Inc. Prepaid Expense, Current
Starling Oncology, Inc. (DFPH) had Prepaid Expense, Current of $4.19 million as of 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:PrepaidExpenseCurrent · last filed 2023-11-08
- 2023-09-30: Prepaid Expense, Current $4.19M.
- 2023-06-30: Prepaid Expense, Current $5.83M.
- 2023-03-31: Prepaid Expense, Current $6.94M.
- 2022-12-31: Prepaid Expense, Current $6.92M.
| Period end | Prepaid Expense, Current | Prepaid Expense, Current as first filed |
|---|---|---|
| 2023-09-30 | $4.19M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $5.83M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $6.94M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $6.92M 10-Q · filed 2023-11-08 | |
| 2022-09-30 | $7.66M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $10.05M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $10.74M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $11.20M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $82.25K 10-Q/A · filed 2021-12-14 | |
| 2021-06-30 | $126.45K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $162.82K 10-Q · filed 2021-05-28 | |
| 2020-12-31 | $2.11M 10-K · filed 2022-03-11 | $152.47K 10-K · filed 2021-03-30 |
| 2020-09-30 | $202.19K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $242.37K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $292.93K 10-Q · filed 2020-05-08 |